An observational study in Beta-Thalassemia, sponsored by Assiut University. Status unknown. Open to participants aged 2 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-28.
Sponsored by Assiut University · Observational
to study the frequency and pattern of dermatological abnormalities in egyptian childern with beta thalassemia.relationof abnormalities to duration of disease and frequency of transfusion
thalassemia refers to agroup of inherited disease characterized by decreased or absent synthesis of normal globin .skinvdisorders are usually neglected and frequently underdiagnosed among these patients.skin disease specially pruritus and xerosis are observed highly frequently in patients with beta-thalassemia.pityriasis alba is arelatively common skin disorder.the trophic skin changes and leg ulcers occurred after the age of 15 years
312 studies on the registry are indexed under beta-Thalassemia; 73 are open to participants now.
This study's planned enrollment of 125 is above the median of 100 across 84 observational studies indexed under beta-Thalassemia.
Browse beta-Thalassemia studies →Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
all patient examined by single dermatologist to record any dermatological abnormalities
Inclusio2n Criteria:
Exclusion Criteria:
thalassemic patient use chelator and thaladssemic patient with frequent blood transfusion
The percentage of patients with dermatological disorders due to iron overload Iron overload cause dermatological abnormalities
the number of patients who develop any dermatological disorder as a result of iron overload after frequent blood transfusion
Time frame: one month
No study locations are listed for this record.
This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.